Anxiety and depressive symptoms affect up to 80% of people with chronic obstructive pulmonary disease (COPD). To reduce this symptom burden, clinicians should target modifiable explanatory factors while accounting for nonmodifiable explanatory factors of these symptoms. The purpose of this secondary data analysis was to examine which modifiable factors explain anxiety and depressive symptoms in COPD. This secondary data analysis of 1,760 COPD patients used multiple regression to explain anxiety and depressive symptoms from sets of modifiable patient characteristics and demographic controls. Clinically significant symptoms of anxiety or depression presented in 29.6% (n = 526) of participants, and 20.6% (n = 363) had both. Significant modifiable explanatory factors of both disorder symptoms were perceived functional status, functional capacity, psychosocial impact, symptom self-management, and significant symptoms for the other. Somatic symptom burden and dyspnea explained anxiety and depressive symptoms, respectively. Addressing these modifiable factors may reduce anxiety and depressive symptoms in patients with COPD.
AbramsT. E.Vaughan-SarrazinM.Vander WegM. W. (2011). Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics, 52(5), 441–449. https://doi.org/10.1016/j.psym.2011.03.005
2.
American Thoracic Society. (2002). ATS statement: Guidelines for the six-minute walk test. American Journal of Respiratory & Critical Care Medicine, 166, 111–117. https://doi.org/10.1164/ajrccm.166.1.at1102
3.
AndersonJ. P.KaplanR. M.BerryC. C.BushJ. W.RumbautR. G. (1989). Interday reliability of function assessment for a health status measure: The quality of well-being scale. Medical Care, 27(11), 1076–1084. http://www.jstor.org/stable/3765526
4.
ArnauR. C.MeagherM. W.NorrisM. P.BramsonR. (2001). Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychology, 20(2), 112–119. https://doi.org/10.1037//0278-6133.20.2.112
5.
BaileyP. H. (2004). The dyspnea-anxiety-dyspnea cycle—COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe.”Qualitative Health Research, 14(6), 760–778. https://doi.org/10.1177/1049732304265973
6.
BarrJ. T.SchumacherG. E.FreemanS.LeMoineM.BakstA. W.JonesP. W. (2000). American translation, modification, and validation of the St. George’s Respiratory Questionnaire. Clinical Therapeutics, 22(9), 1121–1145. https://doi.org/10.1016/S0149-2918(00)80089-2
BrelandJ.HundtN.BarreraT.MignognaJ.PetersenN.StanleyM.CullyJ. (2015). Identification of anxiety symptom clusters in patients with COPD: Implications for assessment and treatment. International Journal of Behavioral Medicine, 22(5), 590–596. https://doi.org/10.1007/s12529-014-9450-2
9.
BugajskiA.FrazierS. K.CousinL.RechenbergK.BrownJ.LengerichA.MoserD. K.LennieT. A. (2019). Effects of a digital self-care intervention in adults with COPD: A pilot study. Western Journal of Nursing Research, 42(9), 736–746. https://doi.org/10.1177/0193945919892282
10.
BugajskiA.SzalachaL.RechenbergK.JohnsonA.BeckieT.MorganH. (2022). Psychometric evaluation of the self-care in chronic obstructive pulmonary disease inventory in the United States. Heart & Lung, 51, 1–8. https://doi.org/10.1016/j.hrtlng.2021.07.004
ClarkA.McDougallG.RiegelB.Joiner-RogersG.InnerarityS.MeravigliaM.DelvilleC.DavilaA. (2015). Health status and self-care outcomes after an education-support intervention for people with chronic heart failure. The Journal of Cardiovascular Nursing, 30(4S Suppl. 1), S3–S13. https://doi.org/10.1097/JCN.0000000000000169
FieldA. (2013). Discovering statistics using SPSS (4th ed.). SAGE Publications.
16.
FishmanA.MartinezF.NaunheimK.PiantadosiS.WiseR.RiesA.WeinmannG.WoodD. E. (2003). A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. New England Journal of Medicine, 348(21), 2059–2073. https://doi.org/10.1056/NEJMoa030287
17.
FjeldsoeB. S.MillerY. D.MarshallA. L. (2012). Text messaging interventions for chronic disease management and health promotion. In NoarS. M.HarringtonN. G. (Eds.), eHealth applications (pp. 180–199). Routledge.
18.
GOLD. (2021). Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2021. https://goldcoped.org/
19.
HoT.CusackR. P.ChaudharyN.SatiaI.KurmiO. P. (2019). Under- and over-diagnosis of COPD: A global perspective. Breathe (Lausanne, Switzerland), 15(1), 24–35. https://doi.org/10.1183/20734735.0346-2018
20.
HwangB.MoserD. K.DracupK. (2014). Knowledge is insufficient for self-care among heart failure patients with psychological distress. Health Psychology, 33(7), 588–596. https://doi.org/10.1037/a0033419
21.
IBM Corp. (2017). IBM SPSS Statistics for Windows, Version 25.0.
22.
IovinoP.De MariaM.MatareseM.VelloneE.AusiliD.RiegelB. (2020). Depression and self-care in older adults with multiple chronic conditions: A multivariate analysis. Journal of Advanced Nursing, 76(7), 1668–1678. https://doi.org/10.1111/jan.14385
23.
JonesP. W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. The European Respiratory Journal, 19(3), 398–404. https://doi.org/10.1183/09031936.02.00063702
KaplanR. M.AtkinsC. J.TimmsR. (1984). Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. Journal of Chronic Disease, 37(2), 85–95. https://doi.org/10.1016/0021-9681(84)90050-X
26.
KinsmanR. A.FernandezE.SchocketM.DirksJ. F.CovinoN. A. (1983). Multidimensional analysis of the symptoms of chronic bronchitis and emphysema. Journal of Behavioral Medicine, 6(4), 339–357. https://doi.org/10.1007/BF00846323
27.
KnightR. G.Waal-ManningH. J.SpearsG. F. (1983). Some norms and reliability data for the State-Trait Anxiety Inventory and the Zung Self-Rating Depression scale. British Journal of Clinical Psychology, 22(4), 245–249. https://doi.org/10.1111/j.2044-8260.1983.tb00610.x
28.
LaurinC.MoullecG.BaconS. L.LavoieK. L. (2012). Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. American Journal of Respiratory & Critical Care Medicine, 185(9), 918–923. https://doi.org/10.1164/rccm.201105-0939PP
LinC. Y.MillerJ. L.LennieT. A.BiddleM. J.Mudd-MartinG.HammashM.MoserD. K. (2020). Perceived control predicts symptom status in patients with heart failure. Journal of Cardiovascular Nursing, 35(6), 30–37. https://doi.org/10.1097/JCN.0000000000000684
31.
LipsonS. K.EmilyG. L.EisenbergD. (2019). Increased rates of mental health service utilization by U.S. college students: 10-year population-level trends (2007–2017). Psychiatric Services, 70(1), 60–63. https://doi.org/10.1176/appi.ps.201800332
32.
MatareseM.ClariM.De MarinisM. G.BarbaranelliC.IvzikuD.PireddaM.RiegelB. (2020). The self-care in chronic obstructive pulmonary disease inventory: Development and psychometric evaluation. Evaluation & the Health Professions, 43(1), 50–62. https://doi.org/10.1177/0163278719856660
33.
MathewA. R.YountS. E.KalhanR.HitsmanB. (2019). Psychological functioning in patients with chronic obstructive pulmonary disease: A preliminary study of relations with smoking status and disease impact. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 21(5), 686–690. https://doi.org/10.1093/ntr/nty102
34.
MoullecG.NinotG. (2010). An integrated programme after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: Effect on emotional and functional dimensions of quality of life. Clinical Rehabilitation, 24(2), 122–136. https://doi.org/10.1177/0269215509346088
35.
NoarS. M.BenacC. N.HarrisM. S. (2007). Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychological Bulletin, 133(4), 673–693. https://doi.org/10.1037/0033-2909.133.4.673
36.
ParkS. K.LarsonJ. L. (2014). Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease. Journal of Clinical Nursing, 23(17–18), 2658–2671. https://doi.org/10.1111/jocn.12526
37.
ParkS. K.MeldrumC. A.LarsonJ. L. (2013). Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease. Heart & Lung, 42(6), 465–472. https://doi.org/10.1016/j.hrtlng.2013.08.008
38.
PoolerA.BeechR. (2014). Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: A systematic review. International Journal of Chronic Obstructive Pulmonary Disease, 9(1), 315–330. https://doi.org/10.2147/COPD.S53255
39.
PuhanM. A.MadorM. J.HeldU.GoldsteinR.GuyattG. H.SchunemannH. J. (2008). Interpretation of treatment changes in 6-minute walk distance in patients with COPD. European Respiratory Journal, 32(3), 637–643. https://doi.org/10.1183/09031936.00140507
40.
RaghavanD.VarkeyA.BartterT. (2017). Chronic obstructive pulmonary disease: The impact of gender. Current Opinion in Pulmonary Medicine, 23(2), 117–123. https://doi.org/10.1097/MCP.0000000000000353
41.
RiegelB.BarbaranelliC.SetharesK. A.DausM.MoserD. K.MillerJ. L.HaedtkeC. A.FeinbergJ. L.LeeS.StrombergA.JaarsmaT. (2018a). Development and initial testing of the self-care of chronic illness inventory. Journal of Advanced Nursing, 74(10), 2465–2476. https://doi.org/10.1111/jan.13775
42.
RiegelB.JaarsmaT.LeeC. S.StrombergA. (2018b). Integrating symptoms into the middle-range theory of self-care of chronic illness. Advances in Nursing Science, 42(3), 206–215. https://doi.org/10.1097/ANS.0000000000000237
43.
RiesA. L. (2005). Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and visual analog scale. COPD, 2(1), 105–110. https://doi.org/10.1081/copd-200050655
44.
SantosG. C.LiljeroosM.DwyerA. A.JaquesC.GirardJ.StrömbergA.HullinR.Schäfer-KellerP. (2021). Symptom perception in heart failure – Interventions and outcomes: A scoping review. International Journal of Nursing Studies, 116, 103524. https://doi.org/10.1016/j.ijnurstu.2020.103524
45.
SchulerM.WittmannM.FallerH.SchultzK. (2018). The interrelations among aspects of dyspnea and symptoms of depression in COPD patients—A network analysis. Journal of Affective Disorders, 240, 33–40. https://doi.org/10.1016/j.jad.2018.07.021
46.
SeiberW. J.GroesslE. J.DavidK. M.GaniatsT. G.KaplanR. M. (2008). Quality of well being self-administered (QWB-SA) scale. Health Services Research Center, University of California. https://hoap.ucsd.edu/qwb-info/qwb-manual.pdf
47.
SpielbergerC. D.GorsuchR. L.LusheneR. E. (1983). Manual for the State-Trait Anxiety Inventory. Consulting Psychologists.
48.
StanleyM. A.BeckJ. G.ZebbB. J. (1996). Psychometric properties of four anxiety measures in older adults. Behaviour Research and Therapy, 34(10), 827–838. https://doi.org/10.1016/0005-7967(96)00064-2
49.
TselebisA.PachiA.IliasI.KosmasE.BratisD.MoussasG.TzanakisN. (2016). Strategies to improve anxiety and depression in patients with COPD: A mental health perspective. Neuropsychiatric Disease and Treatment, 12, 297–328. https://doi.org/10.2147/NDT.S79354
50.
VahratianA.BlumbergS. J.TerlizziE. P.SchillerJ. S. (2021). Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic—United States, August 2020–February 2021. Morbidity Mortality Weekly Report, 70(13), 490–494. http://doi.org/10.15585/mmwr.mm7013e2
51.
von ElmE.AltmanD. G.EggerM.PocockS. J.GotzcheP. C.VandenbrouckeJ. P. (2007). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Bulletin of the World Health Organization, 85(11), 867–872. https://doi.org/10.2471/BLT.07.045120
52.
WareJ. E.SherbourneC. D. (1992). The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection. Medical Care, 30(6), 473–483. http://www.jstor.org/stable/3765916
53.
WareJ. E.Jr.KosinskiM.BaylissM. S.McHorneyC. A.RogersW. H.RaczekA. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Medical Care, 33(4), AS264–AS279. http://www.jstor.org/stable/3766635
54.
WeingaertnerV.ScheveC.GerdesV.Schwarz-EywillM.PrenzelR.BauseweinC.HigginsonI. J.VoltzR.HerichL.SimonS. T. (2014). Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: A cohort study. Journal of Pain and Symptom Management, 48(4), 569–581.E1. https://doi.org/10.1016/j.jpainsymman.2013.11.011
55.
YohannesA. M.AlexopoulosG. S. (2014). Depression and anxiety in patients with COPD. European Respiratory Review, 23(133), 345–349. https://doi.org/10.1183/09059180.00007813
56.
ZwerinkM.Brusse-KeizerM.van der ValkP. D.ZielhuisG. A.MonninkhofE. M.van der PalenJ.FirthP. A.EffingT. (2014). Self management for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2014(3), CD002990. https://doi.org/10.1002/14651858.CD002990.pub3
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
